Isabelle Chabot

1.0k total citations
35 papers, 494 citations indexed

About

Isabelle Chabot is a scholar working on Economics and Econometrics, Political Science and International Relations and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Isabelle Chabot has authored 35 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 7 papers in Political Science and International Relations and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Isabelle Chabot's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Medieval and Early Modern Justice (6 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Isabelle Chabot is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Medieval and Early Modern Justice (6 papers) and Pharmaceutical Practices and Patient Outcomes (5 papers). Isabelle Chabot collaborates with scholars based in Canada, United States and Italy. Isabelle Chabot's co-authors include Jean‐Pierre Grégoire, Jocelyne Moisan, Angela Rocchi, Alain Milot, Isabelle Côté, Jacques LeLorier, Mireille Goetghebeur, Lucie Blais, Martin E. Blackstein and Marc Dorais and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Cancer and Vaccine.

In The Last Decade

Isabelle Chabot

31 papers receiving 461 citations

Peers

Isabelle Chabot
Steffen Thirstrup Denmark
Ken Wong United States
Hsiang‐Wen Lin Taiwan
Daniel Gilden United States
Susanne Danus United States
Kristine Swartz United States
Richard R. Cline United States
Megan Wells United States
Judith Sinclair-Cohen Czechia
Steffen Thirstrup Denmark
Isabelle Chabot
Citations per year, relative to Isabelle Chabot Isabelle Chabot (= 1×) peers Steffen Thirstrup

Countries citing papers authored by Isabelle Chabot

Since Specialization
Citations

This map shows the geographic impact of Isabelle Chabot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Chabot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Chabot more than expected).

Fields of papers citing papers by Isabelle Chabot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Chabot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Chabot. The network helps show where Isabelle Chabot may publish in the future.

Co-authorship network of co-authors of Isabelle Chabot

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Chabot. A scholar is included among the top collaborators of Isabelle Chabot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Chabot. Isabelle Chabot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chabot, Isabelle, et al.. (2024). Disease landscape of advanced HER2-breast cancer patients by treatment line in three EU countries and USA. Future Oncology. 20(25). 1807–1824.
3.
Chamoun, Mira, A. Forget, Isabelle Chabot, Mireille E. Schnitzer, & Lucie Blais. (2022). Difference in drug cost between private and public drug plans in Quebec, Canada. BMC Health Services Research. 22(1). 200–200. 1 indexed citations
4.
Lemière, Catherine, et al.. (2022). Development of a community pharmacy-based intervention for patients with uncontrolled asthma. SHILAP Revista de lepidopterología. 7. 100167–100167. 2 indexed citations
5.
Trigg, Andrew, Elaine Brohan, Kim Cocks, et al.. (2021). Health-related quality of life in pediatric patients with partial onset seizures or primary generalized tonic-clonic seizures receiving adjunctive perampanel. Epilepsy & Behavior. 118. 107938–107938. 8 indexed citations
6.
Zhao, Qi, Rachel Hughes, Binod Neupane, et al.. (2021). Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer. BMC Cancer. 21(1). 758–758. 4 indexed citations
7.
Chabot, Isabelle, et al.. (2015). Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review. ClinicoEconomics and Outcomes Research. 7. 287–287. 12 indexed citations
8.
Chabot, Isabelle, et al.. (2011). La justice des familles : autour de la transmission des biens, des savoirs et des pouvoirs (Europe, nouveau monde, XIIe-XIXe siècles). Persée (Ministère de lEnseignement supérieur et de la Recherche).
9.
Chabot, Isabelle. (2011). La dette des familles : femmes, lignage et patrimoine à Florence aux XIVe et XVe siècles. Cadmus - EUI Research Repository (European University Institute). 1 indexed citations
10.
Chabot, Isabelle, et al.. (2010). Moving Elites: Women and Cultural Transfers in the European Court System. 7(3 Suppl). 97S–99S. 2 indexed citations
11.
12.
Chabot, Isabelle, et al.. (2009). Famiglie e poteri in Italia tra Medioevo ed età moderna. 1 indexed citations
13.
Chabot, Isabelle, Jacques LeLorier, & Martin E. Blackstein. (2008). The challenge of conducting pharmacoeconomic evaluations in oncology using crossover trials: The example of sunitinib for gastrointestinal stromal tumour. European Journal of Cancer. 44(7). 972–977. 27 indexed citations
14.
Grégoire, Jean‐Pierre, Jocelyne Moisan, Louise Potvin, et al.. (2006). Effect of drug utilization reviews on the quality of in-hospital prescribing: a quasi-experimental study. BMC Health Services Research. 6(1). 33–33. 12 indexed citations
15.
Rahme, Elham, Elke Hunsche, Youssef Toubouti, & Isabelle Chabot. (2006). Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: What is the potential impact of the withdrawal of rofecoxib?. Arthritis Care & Research. 55(1). 27–34. 4 indexed citations
16.
Côté, Isabelle, Jocelyne Moisan, Isabelle Chabot, & Jean‐Pierre Grégoire. (2005). Health-related quality of life in hypertension: impact of a pharmacy intervention programme. Journal of Clinical Pharmacy and Therapeutics. 30(4). 355–362. 28 indexed citations
17.
Burgess, Ellen, George W. Carides, William C. Gerth, Michael Marentette, & Isabelle Chabot. (2004). Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective.. PubMed. 20(6). 613–8. 15 indexed citations
18.
Côté, Isabelle, Jean‐Pierre Grégoire, Jocelyne Moisan, Isabelle Chabot, & Guy Lacroix. (2003). A Pharmacy-Based Health Promotion Programme in Hypertension. PharmacoEconomics. 21(6). 415–428. 30 indexed citations
19.
Chabot, Isabelle, Mireille Goetghebeur, & Jean‐Pierre Grégoire. (2003). The societal value of universal childhood vaccination. Vaccine. 22(15-16). 1992–2005. 29 indexed citations
20.
Chabot, Isabelle. (1988). Widowhood and poverty in late medieval Florence. Continuity and Change. 3(2). 291–311. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steffen Thirstrup Breakdown of academic impact, for papers by Ken Wong Breakdown of academic impact, for papers by Hsiang‐Wen Lin Breakdown of academic impact, for papers by Daniel Gilden Breakdown of academic impact, for papers by Susanne Danus Breakdown of academic impact, for papers by Kristine Swartz Breakdown of academic impact, for papers by Richard R. Cline Breakdown of academic impact, for papers by Megan Wells Breakdown of academic impact, for papers by Judith Sinclair-Cohen
Rankless by CCL
2026